Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease
Joint Authors
Kong, Lihong
Yu, Chao-Chao
Jiang, Tao
Yang, Aofei
Du, Yan-Jun
Wu, Miao
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-04-10
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
Tau hyperphosphorylation is a typical pathological change in Alzheimer’s disease (AD) and is involved in the early onset and progression of AD.
Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene.
Epigenetic modifications, such as noncoding RNA regulation, DNA methylation, and histone modification, can directly or indirectly affect the regulation of tau phosphorylation, thereby participating in AD development and progression.
This review summarizes the current research progress on the mechanisms of epigenetic modification associated with tau phosphorylation.
American Psychological Association (APA)
Yu, Chao-Chao& Jiang, Tao& Yang, Aofei& Du, Yan-Jun& Wu, Miao& Kong, Lihong. 2019. Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease. Neural Plasticity،Vol. 2019, no. 2019, pp.1-12.
https://search.emarefa.net/detail/BIM-1201548
Modern Language Association (MLA)
Yu, Chao-Chao…[et al.]. Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease. Neural Plasticity No. 2019 (2019), pp.1-12.
https://search.emarefa.net/detail/BIM-1201548
American Medical Association (AMA)
Yu, Chao-Chao& Jiang, Tao& Yang, Aofei& Du, Yan-Jun& Wu, Miao& Kong, Lihong. Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease. Neural Plasticity. 2019. Vol. 2019, no. 2019, pp.1-12.
https://search.emarefa.net/detail/BIM-1201548
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1201548
